Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ELVN

Enliven Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · ELVN

All alert types
44.25 USD -0.83 -1.84%
As of Oct 30, 2026 Extended hours 44.25 0.00%
Bid
44.21 × 2
Ask
44.26 × 2
44.09 Day range 45.87
15.14 52-week range 61.15
YTD
+187.34%
1 year
+84.61%
Open
44.92
Prev close
45.08
Mkt cap
3.24B
Vol
1.24M
Avg vol
1.35M
EPS
-1.67
P/E
0.00
Div yield
0.00%
More statistics
Low
44.09
High
45.87
Forward P/E
-19.10
Beta
0.34
Short ratio
5.98
Inst. own
115.69%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2026
50-d avg
49.00
200-d avg
42.64
1y target
74.42

5D chart

Chart tools
Interval
1m5m15m30m
ELVN five-day price chart40.841.943.144.245.3Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

129.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -8.4×
FY 2017: 0.0×FY 2018: -22.9×FY 2019: -11.0×FY 2020: -20.5×FY 2021: -2.8×FY 2022: -2.7×FY 2023: -6.9×FY 2024: -11.9×FY 2025: -8.4×
FY 2017 5y median -6.9× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.9×
FY 2017: -16.7×FY 2018: -9.8×FY 2019: -5.3×FY 2020: 4.6×FY 2021: 0.7×FY 2022: -1.3×FY 2023: 2.0×FY 2024: 3.4×FY 2025: 1.9×
FY 2017 5y median 1.9× FY 2025
P/FCF -12.4×
FY 2017: -29.5×FY 2018: -29.5×FY 2019: -11.8×FY 2020: -43.1×FY 2021: -3.6×FY 2022: -3.1×FY 2023: -8.0×FY 2024: -14.5×FY 2025: -12.4×
FY 2017 5y median -8.0× FY 2025
EV/EBITDA -7.5×
FY 2017: 1132×FY 2018: -22.2×FY 2019: -10.9×FY 2020: -36.6×FY 2021: 1.6×FY 2022: -0.7×FY 2023: -5.5×FY 2024: -10.6×FY 2025: -7.5×
FY 2017 5y median -5.5× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -8.1%
FY 2017: -3.4%FY 2018: -3.4%FY 2019: -8.5%FY 2020: -2.3%FY 2021: -27.5%FY 2022: -32.0%FY 2023: -12.5%FY 2024: -6.9%FY 2025: -8.1%
FY 2017 5y median -12.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -22.6%
FY 2017: 0.0%FY 2018: 43.1%FY 2019: 48.0%FY 2020: -22.5%FY 2021: -23.2%FY 2022: 49.0%FY 2023: -29.1%FY 2024: -28.7%FY 2025: -22.6%
FY 2017 5y median -23.2% FY 2025
ROIC -26.0%
FY 2017: 0.0%FY 2018: -181.8%FY 2019: -82.9%FY 2020: -11.0%FY 2021: -23.0%FY 2022: -52.5%FY 2023: -33.9%FY 2024: -33.7%FY 2025: -26.0%
FY 2017 5y median -33.7% FY 2025
ROA -21.8%
FY 2017: 0.0%FY 2018: -147.1%FY 2019: -70.5%FY 2020: -20.9%FY 2021: -21.8%FY 2022: -45.2%FY 2023: -26.3%FY 2024: -27.3%FY 2025: -21.8%
FY 2017 5y median -26.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -14.4%
FY 2017: 0.0%FY 2018: -19.9%FY 2019: -125.9%FY 2020: 61.4%FY 2021: -165.7%FY 2022: -56.7%FY 2023: -115.3%FY 2024: -25.2%FY 2025: -14.4%
FY 2017 FY 2025
EPS (diluted) 3.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -107.3%FY 2020: 20.6%FY 2021: 26.5%FY 2022: -90.2%FY 2023: 66.7%FY 2024: 6.0%FY 2025: 3.2%
FY 2017 FY 2025
Free Cash Flow 3.8%
FY 2017: 0.0%FY 2018: 0.1%FY 2019: -150.8%FY 2020: 59.2%FY 2021: -115.0%FY 2022: -69.2%FY 2023: -87.9%FY 2024: -19.2%FY 2025: 3.8%
FY 2017 FY 2025

Financial Health

Current Ratio 28.7×
FY 2017: 12.4×FY 2018: 4.2×FY 2019: 7.3×FY 2020: 14.5×FY 2021: 19.2×FY 2022: 8.0×FY 2023: 10.3×FY 2024: 20.0×FY 2025: 28.7×
FY 2017 5y median 19.2× FY 2025
Quick Ratio 28.7×
FY 2017: 12.4×FY 2018: 4.2×FY 2019: 7.3×FY 2020: 14.5×FY 2021: 19.2×FY 2022: 8.0×FY 2023: 10.3×FY 2024: 20.0×FY 2025: 28.7×
FY 2017 5y median 19.2× FY 2025
Debt / Equity 0.0×
FY 2017: -0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2017: -40.8×FY 2018: 0.7×FY 2019: 0.2×FY 2020: 5.1×FY 2021: 4.5×FY 2022: 2.0×FY 2023: 1.4×FY 2024: 1.4×FY 2025: 1.0×
FY 2017 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31